title: Tamoxifen and endometrial cancer: new data for an old problem. Review.
abstract: Tamoxifen, a nonsteroidal antiestrogen, is used for pre- and postmenopausal patients with breast cancer. Data on a possible association of endometrial pathologies with Tamoxifen treatment have been accumulating. The current literature and our experience are presented.
authors.affiliation: Department B of the Gynecology and Obstetrics Institute, University of Torino, Italy.
authors.forename: L
authors.initials: L
authors.lastname: Leo
authors.forename: M
authors.initials: M
authors.lastname: Tessarolo
authors.forename: G
authors.initials: G
authors.lastname: Febo
authors.forename: C
authors.initials: C
authors.lastname: Farina
authors.forename: L
authors.initials: L
authors.lastname: Nuzzo
authors.forename: S
authors.initials: S
authors.lastname: Arduino
authors.forename: T
authors.initials: T
authors.lastname: Wierdis
authors.forename: A
authors.initials: A
authors.lastname: Lanza
mesh_terms: D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D016889:Endometrial Neoplasms / Q000188:drug therapy*; D004965:Estrogen Antagonists / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D013629:Tamoxifen / Q000627:therapeutic use*
chemical_list: D018931:Antineoplastic Agents, Hormonal; D004965:Estrogen Antagonists; D013629:Tamoxifen